Beinaglutide showed significant weight-loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real-world setting: a 3-month, multicentre, observational, retrospective, open-label study
Both alcohol and [GLP-1 drugs] can decrease blood sugar levels, and this could be dangerous, particularly in those that are also on insulin or other blood-sugar-lowering medications, says Brianna Johnson-Rabbett, MD, the interim medical director of the American Board of Obesity Medicine
Additionally, new research indicates that tirzepatide potentially has some advantages over traditional metabolic regulation, such as insulin sensitivity improvement and anti-inflammatory effect [2]
In animal studies, side effects have been minimal and mostly gastrointestinal
Lifestyle fundamentals still rule as the most important sustainable body composition change drivers
These results align with prior studies, such as the BARI-OPTIMISE trial [28], which reported a 9.4 kg weight loss with liraglutide in a similar population